Journal article
Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults
Abstract
The CSPPT (China Stroke Primary Prevention Trial) demonstrated a significant risk reduction of first stroke in hypertensive patients treated with enalapril plus folic acid compared with those with enalapril alone, but the lifetime stroke-free survival associated with the treatment is unknown. By establishing adjusted models for competing risks and an age-based time scale using data from 19 053 participants of the CSPPT, we estimated lifetime …
Authors
Zhang T; Lin T; Wang Y; Wang B; Qin X; Xie F; Cui Y; Huo Y; Wang X; Zhang Z
Journal
Hypertension, Vol. 75, No. 2, pp. 339–346
Publisher
Wolters Kluwer
Publication Date
February 2020
DOI
10.1161/hypertensionaha.119.14102
ISSN
0194-911X